Letrozole co-treatment in an antagonist protocol for overweight women undergoing IVF treatment: a retrospective study
Letrozole co-treatment in an antagonist protocol may offer potential benefits for overweight infertile women undergoing IVF treatment. Further research is warranted to validate these findings and explore the broader implications for letrozole co-treatment.
Authors
- Jiaying Lin (ORCID: https://orcid.org/0000-0002-1473-5636)
- Yanwen Zhu (ORCID: https://orcid.org/0009-0000-9422-2779)
- Bian Wang (ORCID: https://orcid.org/0000-0001-8489-2744)
- Jing Lin (ORCID: https://orcid.org/0000-0002-7791-2927)
- Zhengjun Cao
- Fenglu Wu
Institutions
- Shanghai Jiao Tong University (CN)
- XinHua Hospital (CN)
- Shanghai Ninth People's Hospital (CN)
- Central Hospital of Putuo District (CN)
Publication Details
- Journal
- BMC Pregnancy and Childbirth
- Published
- 2024-09-10
- DOI
- https://doi.org/10.1186/s12884-024-06795-3
- Citations
- 3
- Primary Topic
- Ovarian function and disorders
- Type
- article
- Field-Weighted Citation Impact
- 1.61
Funders
- National Natural Science Foundation of China